Recombinant birch allergens (Bet v 1 and Bet v 2) and the oral allergy syndrome in patients allergic to birch pollen

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 5, 2003, Pages 490-492

  De Amici, M ^a,b   Mosca, M ^a   Vignini, M ^a   Quaglini, S ^a   Moratti, R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; POLLEN ANTIGEN; RECOMBINANT BIRCH ALLERGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLERGIC REACTION; ALLERGY TEST; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; FEMALE; FLUOROIMMUNOASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTERMETHOD COMPARISON; MALE; ORAL ALLERGY SYNDROME; POLLEN ALLERGY; PREDICTION; PRICK TEST; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; SKIN SENSITIZATION;

EID: 0344825272     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61519-0     Document Type: Article

References (13)

1. Gluck U. Pollinosis und orales allergie syndrom (OAS). HNO. 1990;38:188-190.
2. Kazemi-Shirazi L, Pauli G, Purohit A, et al. Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol. 2000;105:116-125.
3. De Amici M, Moratti R, Quaglini S, Vignini MA, Mosca M. IgE to Bet v 1/Bet v 2 in UAS. Allergy. 2002;57:181-182.
4. Pauli G, Deviller P. Allergens recombinants: utilisation et perspectives therapeutiques. Rev Mal Respir. 2000;17:293-303.
5. Spangfort MD. Images in allergy and immunology: structure and epitopes of Bet v 1. Int Arch Allergy Immunol. 1997;113:494.
6. Flicker S, Laffer S, Steinberger P, et al. Engineering purification and applications of His-tagged recombinant antibody fragments with specificity for the major birch pollen allergen, bet v1. Biol Chem. 2000;381:39-47.
7. Daschner A, Crespo JF, Pascual CY. Specific IgE to recombinant vegetal panallergen (rBet v 2) and fruit allergy in pollinic patients. Allergy. 1998;53:614-618.
8. Diez-Gomez M, Quirce S, Cuevas M, et al. Fruit-pollen-latex cross-reactivity: implication of profilin (Bet v 2). Allergy. 1999;54:951-961.
9. van Ree R, Fernandez Rivas M, Cuevas M, van Wijngaarden M, Aalberse RC. Pollen related allergy to peach and apple: an important role for profilin. J Allergy Clin Immunol. 1995;95:726-734.
10. Rossi RE, Monasterolo G, Operti D, Corsi M. Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP system in patients with pollen related allergy to birch and apple. Allergy. 1996;51:940-945.
11. Venables WN, Ripley BD. Modern Applied Statistics with S-Plus, Statistics & Computing Series. Berlin, Germany: Springer-Verlag; 1994.
12. Asero R. Detection and clinical characterization of patients with oral allergy syndrome caused by stable allergens in Rosaceae and nuts. Ann Allergy Asthma Immunol. 1999;83:377-383.
13. Faure F, Even J, Kourilsky P. Tumor specific immune response: current analyses may not reflect the in vivo immune status. Crit Rev Immunol. 1998;18:77-86.